CHI3L1 and familial pancreatic carcinoma: Recently, it was reported that plasma YKL-40, carbohydrate antigen 19-9 (CA-19-9) and osteopontin in combination had superior sensitivity for detection of locally advanced, stage II/III pancreatic cancer compared to CA 19-9 alone (93% vs. 80%) [29].